Cannabinoid firm Canntab Therapeutics Restricted (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) launched its on-line e-commerce platform and web site on Thursday. Identified for growing cannabinoid and terpene blends in tablet kind for therapeutic purposes, Canntab is now making them obtainable in a number of doses and timed-release combos.
The e-commerce platform and web site will supply Canadians the chance to supply true medical THC and CBD in pharmaceutical-grade strong tablets. Canntab’s tablet gives sufferers with quite a few advantages akin to ease of use, efficacy, precise dosage and bioavailability.
The Toronto-based firm can script sufferers instantly on-line, absorb current or new prescriptions from docs and even share a prescription with one other LP. Canntab and its patented formulations is the one supplier of THC and CBD in tablet kind in Canada.
“Right this moment marks one other important milestone within the historical past of Canntab,” Larry Latowsky, CEO of Canntab acknowledged. “We’re excited to launch our E-Commerce platform and website making medical-grade THC and CBD accessible to all Canadians. So many medical sufferers have been anticipating the launch of our web site to buy our THC and CBD strong precise dosage pharmaceutical grade product to assist with assuaging widespread medical circumstances together with ache, irritation, stress, nervousness and sleep to call just a few.”
Newer information from Canntab:
Levitee Labs Teams Up With Canntab Therapeutics, Offer Cannabinoid Products As Alternatives To Opioids
Canntab Therapeutics Completes First Shipment Of THC Tablets To Ontario Cannabis Stores
Canntab shares traded flat at 60 cents per share on the time of writing Thursday.